RGC-32 as a potential marker of relapse and response to treatment with glatiramer acetate in multiple sclerosis

2015 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []